Real-time enrollment status for this dystrophic epidermolysis bullosa clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 10:14 AM UTC
| NCT Number | NCT06892639 |
| Recruiting Status | Recruiting |
| Condition | Dystrophic Epidermolysis Bullosa |
| Phase | Clinical Trial |
| Target Enrollment | 32 participants |
| Active Locations | 4 sites in the US |
| Sponsor | Castle Creek Biosciences, LLC. |
| Last Updated on CT.gov | February 11, 2026 (2 weeks ago) |
As of March 2, 2026: Clinical trial NCT06892639 is currently recruiting participants. This clinical trial study for dystrophic epidermolysis bullosa is actively seeking new participants at 4 locations across the United States. The study is sponsored by Castle Creek Biosciences, LLC.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06892639 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 4 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06892639 was last updated 2 weeks ago (February 11, 2026). HelloStudys verifies this status automatically.